Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Mortality from coronary heart disease in the United States has decreased substantially in recent decades. We conducted a study to determine how much of this decrease could be explained by the use of medical and surgical treatments as opposed to changes in cardiovascular risk factors. METHODS: We applied a previously validated statistical model, IMPACT, to data on the use and effectiveness of specific cardiac treatments and on changes in risk factors between 1980 and 2000 among U.S. adults 25 to 84 years old. The difference between the observed and expected number of deaths from coronary heart disease in 2000 was distributed among the treatments and risk factors included in the analyses. RESULTS: From 1980 through 2000, the age-adjusted death rate for coronary heart disease fell from 542.9 to 266.8 deaths per 100,000 population among men and from 263.3 to 134.4 deaths per 100,000 population among women, resulting in 341,745 fewer deaths from coronary heart disease in 2000. Approximately 47% of this decrease was attributed to treatments, including secondary preventive therapies after myocardial infarction or revascularization (11%), initial treatments for acute myocardial infarction or unstable angina (10%), treatments for heart failure (9%), revascularization for chronic angina (5%), and other therapies (12%). Approximately 44% was attributed to changes in risk factors, including reductions in total cholesterol (24%), systolic blood pressure (20%), smoking prevalence (12%), and physical inactivity (5%), although these reductions were partially offset by increases in the body-mass index and the prevalence of diabetes, which accounted for an increased number of deaths (8% and 10%, respectively). CONCLUSIONS: Approximately half the decline in U.S. deaths from coronary heart disease from 1980 through 2000 may be attributable to reductions in major risk factors and approximately half to evidence-based medical therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Between 1950 and 1970 most of the decline in mortality rates from CVD was due to prevention (Goldman & Cook, 1984), whereas acute disease management and medical treatments accounted for about half of the decline between 1980 and 2000 (Ford et al., 2007).”
From Mortality and Morbidity Trends: Is There Compression of Morbidity? (2011) · cites this paper as Ford et al., 2007
In the citing paper
“Past studies show the effect of access to high-quality personal health care on both communicable and non-communicable diseases, highlighting the importance of prioritising personal health-care access and quality for all populations across the development spectrum.39–42”
In the citing paper
“Prevention works: .50% of the reductions seen in CHD mortality relate to changes in risk factors, and 40% to improved treatments.”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [29]
In the citing paper
“Another approach to understanding the changes in CVD mortality and incidence rates is by applying models such as the IMPACT mortality model.29 Based on information on changes in coronary risk factors and in treatment as obtained from the results of RCTs regarding the effectiveness of different treatment modalities, it estimates the expected influence on CHD mortality by age and gender.”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [29]
In the citing paper
“Beneficial reductions in major risk factors-in particular smoking, BP, and cholesterol-accounted for more than half of the decrease in CHD deaths, although they were counteracted by an increase in the prevalence of obesity and type 2 diabetes; 40% of the decline in CHD death rates is attributed to better treatments of acute myocardial infarction, heart failure, and other cardiac conditions.”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [29]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Prevalence of Overweight and Obesity Among US Children, Adolescents, and Adults, 1999-2002
Hedley, A. A. (2004) · JAMA · doi:10.1001/jama.291.23.2847 · Cited by 4,460
Writing Group Members, Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Manolio, T., Zheng, Z.-J., Flegal, K., O’Donnell, C., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.171600 · Cited by 3,451
Rosamond, W., Flegal, K., Friday, G., Furie, K., Go, A., Greenlund, K., Haase, N., Ho, M., Howard, V., Kissela, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.179918 · Cited by 3,277
Excess Deaths Associated With Underweight, Overweight, and Obesity
Flegal, K. M. (2005) · JAMA · doi:10.1001/jama.293.15.1861 · Cited by 2,824
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmsr043743 · Cited by 2,612
Hajjar, I. (2003) · JAMA · doi:10.1001/jama.290.2.199 · Cited by 2,409
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000167407.83915.e7 · Cited by 1,944
Research works printed but not linked: 3
- 2004, MMWR Morb Mortal Wkly Rep, 53, 82
- Ryan R, 2001, Health Stat Q, 12, 34
- Mokdad AH, 2003, MMWR Recomm Rep, 52, 1
Cited by
Items 101–200 of 1,006
Puymirat, E. (2012) · JAMA · doi:10.1001/2012.jama.11348 · Cited by 494
Fox, C. S., Golden, S. H., Anderson, C., Bray, G. A., Burke, L. E., de Boer, I. H., Deedwania, P., Eckel, R. H., Ershow, A. G., Fradkin, J., et al. (2015) · Diabetes Care · doi:10.2337/dci15-0012 · Cited by 492
9. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s009 · Cited by 485
Astrup, A., Dyerberg, J., Elwood, P., Hermansen, K., Hu, F. B., Jakobsen, M. U., Kok, F. J., Krauss, R. M., Lecerf, J. M., LeGrand, P., et al. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.004622 · Cited by 487
Breast Tissue Composition and Susceptibility to Breast Cancer
Boyd, N. F., Martin, L. J., Bronskill, M., Yaffe, M. J., Duric, N., & Minkin, S. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq239 · Cited by 478
Gregg, E. W., Cheng, Y. J., Srinivasan, M., Lin, J., Geiss, L. S., Albright, A. L., & Imperatore, G. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30314-3 · Cited by 480
Gersh, B. J., Sliwa, K., Mayosi, B. M., & Yusuf, S. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq030 · Cited by 465
Micha, R., Khatibzadeh, S., Shi, P., Andrews, K. G., Engell, R. E., & Mozaffarian, D. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-008705 · Cited by 473
Schmidt, M., Jacobsen, J. B., Lash, T. L., Botker, H. E., & Sorensen, H. T. (2012) · BMJ · doi:10.1136/bmj.e356 · Cited by 461
Mortality Trends in Men and Women with Diabetes, 1971 to 2000
Gregg, E. W., Gu, Q., Cheng, Y. J., Venkat Narayan, K. M., & Cowie, C. C. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-3-200708070-00167 · Cited by 463
Medication adherence: a call for action
Bosworth, H. B., Granger, B. B., Mendys, P., Brindis, R., Burkholder, R., Czajkowski, S. M., Daniel, J. G., Ekman, I., Ho, M., Johnson, M., et al. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.007 · Cited by 448
Perspectives and opportunities for nanomedicine in the management of atherosclerosis
Lobatto, M. E., Fuster, V., Fayad, Z. A., & Mulder, W. J. M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3578 · Cited by 423
Technology Growth and Expenditure Growth in Health Care
Chandra, A., & Skinner, J. (2012) · Journal of Economic Literature · doi:10.1257/jel.50.3.645 · Cited by 412
Kris-Etherton, P. M., Hu, F. B., Ros, E., & Sabaté, J. (2008) · The Journal of Nutrition · doi:10.1093/jn/138.9.1746s · Cited by 410
Tu, J. V., Nardi, L., Fang, J., Liu, J., Khalid, L., Johansen, H., & for the Canadian Cardiovascular Outcomes Research Team (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.081197 · Cited by 409
Multiple health behaviours: overview and implications
Spring, B., Moller, A. C., & Coons, M. J. (2012) · Journal of Public Health · doi:10.1093/pubmed/fdr111 · Cited by 408
The Burden of Cardiovascular Diseases Among US States, 1990-2016
Global Burden of Cardiovascular Diseases Collaboration, Roth, G. A., Johnson, C. O., Abate, K. H., Abd-Allah, F., Ahmed, M., Alam, K., Alam, T., Alvis-Guzman, N., Ansari, H., et al. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.0385 · Cited by 389
Jaswal, J. S., Keung, W., Wang, W., Ussher, J. R., & Lopaschuk, G. D. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.015 · Cited by 400
Fox, C. S., Golden, S. H., Anderson, C., Bray, G. A., Burke, L. E., de Boer, I. H., Deedwania, P., Eckel, R. H., Ershow, A. G., Fradkin, J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000230 · Cited by 386
Ford, E. S., Greenlund, K. J., & Hong, Y. (2012) · Circulation · doi:10.1161/circulationaha.111.049122 · Cited by 378
Self-citationParikh, N. I., Gona, P., Larson, M. G., Fox, C. S., Benjamin, E. J., Murabito, J. M., O'Donnell, C. J., Vasan, R. S., & Levy, D. (2009) · Circulation · doi:10.1161/circulationaha.108.825364 · Cited by 149
Mosca, L., Hammond, G., Mochari-Greenberger, H., Towfighi, A., & Albert, M. A. (2013) · Circulation · doi:10.1161/cir.0b013e318287cf2f · Cited by 357
Anxiety and new onset of cardiovascular disease: critical review and meta-analysis
Batelaan, N. M., Seldenrijk, A., Bot, M., van Balkom, A. J. L. M., & Penninx, B. W. J. H. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.156554 · Cited by 362
Lifestyle Strategies for Risk Factor Reduction, Prevention, and Treatment of Cardiovascular Disease
Rippe, J. M. (2019) · American Journal of Lifestyle Medicine · doi:10.1177/1559827618812395 · Cited by 312
Temporal Trends in the Frequency of Inducible Myocardial Ischemia During Cardiac Stress Testing
Rozanski, A., Gransar, H., Hayes, S. W., Min, J., Friedman, J. D., Thomson, L. E. J., & Berman, D. S. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.056 · Cited by 354
Global Trends in Atherosclerotic Cardiovascular Disease
Nedkoff, L., Briffa, T., Zemedikun, D., Herrington, S., & Wright, F. L. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.09.020 · Cited by 316
Sodium-Glucose Co-transporters and Their Inhibition: Clinical Physiology
Ferrannini, E. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.011 · Cited by 340
A Polypill Strategy to Improve Adherence
Castellano, J. M., Sanz, G., Peñalvo, J. L., Bansilal, S., Fernández-Ortiz, A., Alvarez, L., Guzmán, L., Linares, J. C., García, F., D’Aniello, F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.08.021 · Cited by 349
Dong, C., Rundek, T., Wright, C. B., Anwar, Z., Elkind, M. S. V., & Sacco, R. L. (2012) · Circulation · doi:10.1161/circulationaha.111.081083 · Cited by 338
Cardiovascular comorbidity in rheumatic diseases
Nurmohamed, M. T., Heslinga, M., & Kitas, G. D. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.112 · Cited by 325
Pearson-Stuttard, J., Bennett, J., Cheng, Y. J., Vamos, E. P., Cross, A. J., Ezzati, M., & Gregg, E. W. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30431-9 · Cited by 335
Regensteiner, J. G., Golden, S., Huebschmann, A. G., Barrett-Connor, E., Chang, A. Y., Chyun, D., Fox, C. S., Kim, C., Mehta, N., Reckelhoff, J. F., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000343 · Cited by 334
Lifestyle Medicine: The Health Promoting Power of Daily Habits and Practices
Rippe, J. M. (2018) · American Journal of Lifestyle Medicine · doi:10.1177/1559827618785554 · Cited by 288
A Community-Based Intervention for Managing Hypertension in Rural South Asia
Jafar, T. H., Gandhi, M., de Silva, H. A., Jehan, I., Naheed, A., Finkelstein, E. A., Turner, E. L., Morisky, D., Kasturiratne, A., Khan, A. H., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911965 · Cited by 303
Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, W. M. M., Albus, C., Benlian, P., Boysen, G., Cifkova, R., et al. (2012) · International Journal of Behavioral Medicine · doi:10.1007/s12529-012-9242-5 · Cited by 311
McWilliams, J. M., Meara, E., Zaslavsky, A. M., & Ayanian, J. Z. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-8-200904210-00005 · Cited by 315
Wijeysundera, H. C. (2010) · JAMA · doi:10.1001/jama.2010.580 · Cited by 312
Observational research--opportunities and limitations
Boyko, E. J. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.07.007 · Cited by 313
Risk Factors for Heart Failure: A Population-Based Case-Control Study
Dunlay, S. M., Weston, S. A., Jacobsen, S. J., & Roger, V. L. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.04.022 · Cited by 298
Lovibond, K., Jowett, S., Barton, P., Caulfield, M., Heneghan, C., Hobbs, F. R., Hodgkinson, J., Mant, J., Martin, U., Williams, B., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61184-7 · Cited by 311
Gregg, E. W., Zhuo, X., Cheng, Y. J., Albright, A. L., Narayan, K. M. V., & Thompson, T. J. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70161-5 · Cited by 301
The “Million Hearts” Initiative — Preventing Heart Attacks and Strokes
Frieden, T. R., & Berwick, D. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmp1110421 · Cited by 310
Ford, E. S., & Capewell, S. (2011) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031210-101211 · Cited by 300
Self-citationSteinberger, J., Daniels, S. R., Hagberg, N., Isasi, C. R., Kelly, A. S., Lloyd-Jones, D., Pate, R. R., Pratt, C., Shay, C. M., Towbin, J. A., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000441 · Cited by 299
Wadhera, R. K., Steen, D. L., Khan, I., Giugliano, R. P., & Foody, J. M. (2016) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.11.010 · Cited by 306
70-year legacy of the Framingham Heart Study
Andersson, C., Johnson, A. D., Benjamin, E. J., Levy, D., & Vasan, R. S. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0202-5 · Cited by 305
Yu, Y., Arah, O. A., Liew, Z., Cnattingius, S., Olsen, J., Sørensen, H. T., Qin, G., & Li, J. (2019) · BMJ · doi:10.1136/bmj.l6398 · Cited by 305
Trends in Death Rates Among U.S. Adults With and Without Diabetes Between 1997 and 2006
Gregg, E. W., Cheng, Y. J., Saydah, S., Cowie, C., Garfield, S., Geiss, L., & Barker, L. (2012) · Diabetes Care · doi:10.2337/dc11-1162 · Cited by 303
Self care in patients with chronic heart failure
Riegel, B., Lee, C. S., & Dickson, V. V. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.95 · Cited by 291
Salzwedel, A., Jensen, K., Rauch, B., Doherty, P., Metzendorf, M.-I., Hackbusch, M., Völler, H., Schmid, J.-P., & Davos, C. H. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487320905719 · Cited by 274
Fatty acids in cardiovascular health and disease: A comprehensive update
Baum, S. J., Kris-Etherton, P. M., Willett, W. C., Lichtenstein, A. H., Rudel, L. L., Maki, K. C., Whelan, J., Ramsden, C. E., & Block, R. C. (2012) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2012.04.077 · Cited by 277
Similar mortality rates in hip fracture patients over the past 31 years: A systematic review of RCTs
Mundi, S., Pindiprolu, B., Simunovic, N., & Bhandari, M. (2014) · Acta Orthopaedica · doi:10.3109/17453674.2013.878831 · Cited by 272
Singh-Manoux, A., Fayosse, A., Sabia, S., Tabak, A., Shipley, M., Dugravot, A., & Kivimäki, M. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002571 · Cited by 263
Heart Disease and Cancer Deaths — Trends and Projections in the United States, 1969–2020
Weir, H. K., Anderson, R. N., Coleman King, S. M., Soman, A., Thompson, T. D., Hong, Y., Moller, B., & Leadbetter, S. (2016) · Preventing Chronic Disease · doi:10.5888/pcd13.160211 · Cited by 270
Bruckert, E., Labreuche, J., & Amarenco, P. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.12.023 · Cited by 273
Canto, J. G., Kiefe, C. I., Rogers, W. J., Peterson, E. D., Frederick, P. D., French, W. J., Gibson, C. M., Pollack, C. V., Ornato, J. P., Zalenski, R. J., et al. (2011) · JAMA · doi:10.1001/jama.2011.1654 · Cited by 258
Trends and Patterns of Geographic Variation in Cardiovascular Mortality Among US Counties, 1980-2014
Roth, G. A., Dwyer-Lindgren, L., Bertozzi-Villa, A., Stubbs, R. W., Morozoff, C., Naghavi, M., Mokdad, A. H., & Murray, C. J. L. (2017) · JAMA · doi:10.1001/jama.2017.4150 · Cited by 270
Senthong, V., Wang, Z., Li, X. S., Fan, Y., Wu, Y., Wilson Tang, W. H., & Hazen, S. L. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002816 · Cited by 270
Metabolic Syndrome: Clinical and Policy Implications of the New Silent Killer
Sherling, D. H., Perumareddi, P., & Hennekens, C. H. (2017) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248416686187 · Cited by 268
Telehealth interventions for the secondary prevention of coronary heart disease: a systematic review
Neubeck, L., Redfern, J. U., Fernandez, R., Briffa, T., Bauman, A., & Freedman, S. B. (2009) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e32832a4e7a · Cited by 268
Gender and racial disparities in adherence to statin therapy: A meta-analysis
Lewey, J., Shrank, W. H., Bowry, A. D. K., Kilabuk, E., Brennan, T. A., & Choudhry, N. K. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.02.011 · Cited by 267
Is American Health Care Uniquely Inefficient?
Garber, A. M., & Skinner, J. (2008) · Journal of Economic Perspectives · doi:10.1257/jep.22.4.27 · Cited by 259
Temporal Trends in Mortality in the United States, 1969-2013
Ma, J., Ward, E. M., Siegel, R. L., & Jemal, A. (2015) · JAMA · doi:10.1001/jama.2015.12319 · Cited by 259
Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002
Björck, L., Rosengren, A., Bennett, K., Lappas, G., & Capewell, S. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehn554 · Cited by 264
Self-citationComposite scaffold provides a cell delivery platform for cardiovascular repair
Godier-Furnémont, A. F. G., Martens, T. P., Koeckert, M. S., Wan, L., Parks, J., Arai, K., Zhang, G., Hudson, B., Homma, S., & Vunjak-Novakovic, G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104619108 · Cited by 259
Pearson, T. A., Palaniappan, L. P., Artinian, N. T., Carnethon, M. R., Criqui, M. H., Daniels, S. R., Fonarow, G. C., Fortmann, S. P., Franklin, B. A., Galloway, J. M., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31828f8a94 · Cited by 246
Self-citationUrban-Rural Differences in Coronary Heart Disease Mortality in the United States: 1999–2009
Kulshreshtha, A., Goyal, A., Dabhadkar, K., Veledar, E., & Vaccarino, V. (2014) · Public Health Reports® · doi:10.1177/003335491412900105 · Cited by 252
Precision medicine in cardiology
Antman, E. M., & Loscalzo, J. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.101 · Cited by 250
Predicting In-Hospital Mortality in Patients With Acute Myocardial Infarction
McNamara, R. L., Kennedy, K. F., Cohen, D. J., Diercks, D. B., Moscucci, M., Ramee, S., Wang, T. Y., Connolly, T., & Spertus, J. A. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.05.049 · Cited by 249
Global Perspective on Acute Coronary Syndrome: A Burden on the Young and Poor
Vedanthan, R., Seligman, B., & Fuster, V. (2014) · Circulation Research · doi:10.1161/circresaha.114.302782 · Cited by 243
Shiels, M. S., Chernyavskiy, P., Anderson, W. F., Best, A. F., Haozous, E. A., Hartge, P., Rosenberg, P. S., Thomas, D., Freedman, N. D., & de Gonzalez, A. B. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30187-3 · Cited by 242
Patel, S. A., Winkel, M., Ali, M. K., Narayan, K. M. V., & Mehta, N. K. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1753 · Cited by 240
Reduction in Cardiovascular Death After Kidney Transplantation
Pilmore, H., Dent, H., Chang, S., McDonald, S. P., & Chadban, S. J. (2010) · Transplantation · doi:10.1097/tp.0b013e3181caeead · Cited by 238
Peterson, E. D., Shah, B. R., Parsons, L., Pollack, C. V., French, W. J., Canto, J. G., Gibson, C. M., & Rogers, W. J. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.07.028 · Cited by 247
Nordic Health Care Systems: Recent Reforms And Current Policy Challenges
Magnussen, J., Vrangbæk, K., & Saltman, R. B. (2009) · Cited by 366
US life expectancy stalls due to cardiovascular disease, not drug deaths
Mehta, N. K., Abrams, L. R., & Myrskylä, M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1920391117 · Cited by 240
Boytsov, S. A., Balanova, Y. A., Shalnova, S. A., Deev, A. D., Artamonova, G. V., Gatagonova, T. M., Duplyakov, D. V., Efanov, A. Y., Zhernakova, Y. V., Konradi, A. O., et al. (2014) · Cardiovascular Therapy and Prevention · doi:10.15829/1728-8800-2014-4-4-14 · Cited by 231
The Impact of the Aging Population on Coronary Heart Disease in the United States
Odden, M. C., Coxson, P. G., Moran, A., Lightwood, J. M., Goldman, L., & Bibbins-Domingo, K. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.04.010 · Cited by 235
The mobile revolution—using smartphone apps to prevent cardiovascular disease
Neubeck, L., Lowres, N., Benjamin, E. J., Freedman, S. B., Coorey, G., & Redfern, J. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.34 · Cited by 232
2023 Chinese guideline for lipid management
Li, J.-J., Zhao, S.-P., Zhao, D., Lu, G.-P., Peng, D.-Q., Liu, J., Chen, Z.-Y., Guo, Y.-L., Wu, N.-Q., Yan, S.-K., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1190934 · Cited by 223
Social epidemiology: social determinants of health in the United States: are we losing ground?
Berkman, L. F. (2009) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.031308.100310 · Cited by 230
Lee, D. S., Chiu, M., Manuel, D. G., Tu, K., Wang, X., Austin, P. C., Mattern, M. Y., Mitiku, T. F., Svenson, L. W., Putnam, W., et al. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.081629 · Cited by 225
Physician gender is associated with the quality of type 2 diabetes care
Berthold, H. K., Gouni‐Berthold, I., Bestehorn, K. P., Böhm, M., & Krone, W. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01967.x · Cited by 216
Kremers, H. M., Crowson, C. S., Therneau, T. M., Roger, V. L., & Gabriel, S. E. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23650 · Cited by 221
Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996–2014)
Awan, A. A., Niu, J., Pan, J. S., Erickson, K. F., Mandayam, S., Winkelmayer, W. C., Navaneethan, S. D., & Ramanathan, V. (2018) · American Journal of Nephrology · doi:10.1159/000495081 · Cited by 213
Digital Assessment of Endothelial Function and Ischemic Heart Disease in Women
Matsuzawa, Y., Sugiyama, S., Sugamura, K., Nozaki, T., Ohba, K., Konishi, M., Matsubara, J., Sumida, H., Kaikita, K., Kojima, S., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.073 · Cited by 221
Economic burden of physical inactivity: healthcare costs associated with cardiovascular disease
Oldridge, N. B. (2008) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3282f19d42 · Cited by 218
Hemingway, H., Asselbergs, F. W., Danesh, J., Dobson, R., Maniadakis, N., Maggioni, A., van Thiel, G. J. M., Cronin, M., Brobert, G., Vardas, P., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx487 · Cited by 209
Stemming the global tsunami of cardiovascular disease
Anand, S. S., & Yusuf, S. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62346-x · Cited by 216
Potent Antihypertensive Action of Dietary Flaxseed in Hypertensive Patients
Rodriguez-Leyva, D., Weighell, W., Edel, A. L., LaVallee, R., Dibrov, E., Pinneker, R., Maddaford, T. G., Ramjiawan, B., Aliani, M., Guzman, R., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.02094 · Cited by 207
Effectiveness of Ambulatory Telemedicine Care in Older Adults: A Systematic Review
Batsis, J. A., DiMilia, P. R., Seo, L. M., Fortuna, K. L., Kennedy, M. A., Blunt, H. B., Bagley, P. J., Brooks, J., Brooks, E., Kim, S. Y., et al. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15959 · Cited by 202
Pasanen, K., Parkkari, J., Pasanen, M., Hiilloskorpi, H., Mäkinen, T., Järvinen, M., & Kannus, P. (2008) · British Journal of Sports Medicine · doi:10.1136/bmj.a295 · Cited by 187
Stergiopoulos, K. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.1484 · Cited by 212
Electrocardiograms Should Be Included in Preparticipation Screening of Athletes
Myerburg, R. J., & Vetter, V. L. (2007) · Circulation · doi:10.1161/circulationaha.107.733519 · Cited by 210
The NHS outcomes framework 2012-3
Cromwell, D. A., & Mays, N. (2012) · BMJ · doi:10.1136/bmj.e1080 · Cited by 208
Paz-Elizur, T., Sevilya, Z., Leitner-Dagan, Y., Elinger, D., Roisman, L. C., & Livneh, Z. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.032 · Cited by 201
Dyck, G. J. B., Raj, P., Zieroth, S., Dyck, J. R. B., & Ezekowitz, J. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040904 · Cited by 200
Jafar, T. H., Hatcher, J., Poulter, N., Islam, M., Hashmi, S., Qadri, Z., Bux, R., Khan, A., Jafary, F. H., Hameed, A., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-9-200911030-00004 · Cited by 202
Cardiac cell therapy: where we've been, where we are, and where we should be headed
Malliaras, K., & Marban, E. (2011) · British Medical Bulletin · doi:10.1093/bmb/ldr018 · Cited by 202
Ades, P. A., Savage, P. D., Toth, M. J., Harvey-Berino, J., Schneider, D. J., Bunn, J. Y., Audelin, M. C., & Ludlow, M. (2009) · Circulation · doi:10.1161/circulationaha.108.834184 · Cited by 202
Metadata
- Authors
- Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Newcastle University (GB)
- HealthPartners (US)
- University of Liverpool (GB)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-06-07
- Volume
- 356
- Issue
- 23
- Pages
- 2388-2398
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2150278133
- Cited by
- 2,757
- References
- 44
- Citations by year
- 2026: 56 · 2025: 66 · 2024: 60 · 2023: 82 · 2022: 100 · 2021: 101 · 2020: 114 · 2019: 129 · 2018: 129 · 2017: 153 · 2016: 163 · 2015: 209 · 2014: 173 · 2013: 198 · 2012: 252
- FWCI
- 127.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Keywords
- coronary heart disease mortality, mortality decline, cardiovascular risk factors, IMPACT model, secondary prevention after myocardial infarction, revascularization, acute myocardial infarction treatment, unstable angina, heart failure treatment, cholesterol lowering, blood pressure reduction, smoking, physical inactivity, body mass index, diabetes mellitus, sex differences in mortality
- MeSH terms
- Adult, Aged, Aged, 80 and over, Coronary Disease, Female, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Revascularization, Risk Factors, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.